The following people constitute the Editorial Board of Academic Editors for PeerJ. These active academics are the Editors who seek peer reviewers, evaluate their responses, and make editorial decisions on each submission to the journal. Learn more about becoming an Editor.
Max Planck Research Group Leader since 2014; assistant professor at Radboud University Nijmegen; PostDocs at University of Leuven and University of Strasbourg; PhD in Biophysics from Ludwig Maximilian University Munich; Research interests: mechanobiology, molecular force sensors, protein engineering, single molecule techniques (force and fluorescence); Editor of Biophysical Reviews and Letters
My primary research field is mammalian epigenetic control. My interests lie in using screens to identify novel epigenetic modifiers or new roles for known epigenetic modifiers, in order that we can expand our understanding of the molecular basis of epigenetic control. We study X chromosome inactivation in differentiating ES cells and early embryos, haematopoietic stem cells, neural stem cells and additionally study the role of the epigenetic modifier Smchd1 in the muscular dystrophy FSHD.
2011-:Schools of Cellular & Molecular Medicine and Biochemistry, University of Bristol: Reader in Microbiology.
2007-2011: as above, Senior Lecturer in Microbiology.
2001-2007: Dunn School of Pathology, University of Oxford: Guy Newton Senior Research Fellow.
1997-2000: Institute Pasteur, Paris: Postdoctoral fellow.
1996: EMBL, Heidelberg: Postdoctoral fellow.
1991-1995: EMBL, Heidelberg: PhD in Cell Biology
1988-1991: University College, London: B. Sc. in Genetics, 1st class.
Melanie Blokesch holds a PhD degree from the Ludwig-Maximilians-Universität in Munich, Germany. After a postdoctoral stay at Stanford University (USA; Department of Microbiology and Immunology) from 2005-2009 she joined the Swiss Federal Institute of Technology Lausanne (EPFL) in Lausanne, Switzerland as a tenure-track assistant professor in 2009.
A.W. and Mary Margaret Clausen Distinguished Professor and Director, Hormone Research Institute. Serves on the Science Translational Medicine advisory board and founding Director, Immune Tolerance Network. A recipient of a Guggenheim Fellowship and elected member of the Academy of Arts and Sciences and National Academy of Medicine. Dr. Bluestone has spent over 35 years working as an immunologist interested in immune tolerance as it relates to autoimmunity and organ transplantation.
2013- Senior Lecturer, University of Manchester, Manchester, UK
2006-13 Lecturer, University of Manchester, Manchester, UK
2001-06 Junior Group Leader Max-Planck Institute of Immunobiology in Freiburg, Germany
2000-01 Postdoctoral Fellow, Max-Planck Institute of Immunobiology in Freiburg, Germany
1996 PhD, University of Genova, Italy and Institute of Molecular Pathology, Vienna, Austria
1989 Degree in Biological Sciences, University of Genoa, Italy
Wadsworth Endowed Chair in Conservation Science and Prof. of Biology, University of Washington, Director for Center for Penguins as Ocean Sentinels and the Wildlife Conservation Society Magellanic Penguin Project, and Adjunct Curator of Ornithology, Burke Museum. Recipient of 2012 Ocean Conservation Award Aquarium of the Pacific, 2010 Nature Conservancy of Washington Environmental Hero, 2009 Annual Heinz Award for the Environment. Former President of the Society of Conservation Biology.
Associate Scientist, Childrens' Hospital Oakland Research Institute. Visiting Scholar, University of California, Berkeley.
At CHORI, we use genomic strategies to investigate the role of genetic and epigenetic variation in the regulatory domain of the genome, with an interest in both human disease and evolution. The two main areas of interest of the lab are:The evolutionary biology and potential contribution to human disease of components of the epigenome. And, annotating the regulatory elements of the human genome using a combination of comparative analysis of sequenced vertebrate genomes and public epigenomic datasets.
Obtained her PhD degree in the University of Paris VII in 1993, and trained as a post-doc in Prof. John Dick’s group in Toronto. In 1998, she became Group Leader at the Coriell Institute for Medical Research and Assistant Professor, University of Medicine and Dentistry of New Jersey. In 2001, she joined the London Research Institute. Since 2002, she is also Professor, University College of London and Senior Lecturer at the Institute of Child Health.
Research Fellow at the University of New South Wales working on complex network analysis (brain networks, muscle networks and social networks), electrophysiology, motor control and mental health.
Dr. Glen Borchert holds joint appointments as an Assistant Professor in Biology and Pharmacology at the University of South Alabama. He originally received a B.S. in Biology from the University of Tennessee then completed a Ph.D. in Genetics from the University of Iowa. Dr. Borchert’s research focuses largely on identifying novel genetic regulators and defining their roles in oncogenesis, microbiology and speciation. Since starting his laboratory at South Alabama in August 2012, Dr. Borchert has published dozens of papers in peer reviewed journals and had numerous grant applications funded including a highly prestigious NSF CAREER award (2014-2019).
Interested in: Perception and action - Affordances - Social and relational affordances; Language grounding in sensorimotor processes; Impact of language on categorization and sense of body; Categorization and conceptualization. Using mostly experimental laboratory methods (behavioral and kinematics studies), but also computer simulations (neural networks).